Le Lézard
Classified in: Health
Subject: TRI

Soin Neuroscience commences a clinical case series with Nuvectra's Algovita spinal cord stimulator for back pain



DAYTON, Ohio, March 8, 2018 /PRNewswire/ -- Soin Neuroscience, a biotech company based in Dayton, OH, has received IRB (institutional review board) approval to commence a clinical case series to study spinal cord stimulator algorithms in patients who suffer from back pain. Dr Amol Soin, a pain management physician and CEO of Soin Neuroscience, will be running the study in Dayton, OH. "I look forward to using Nuvectra's Algovita, and its powerful spinal cord stimulator system to treat patients with back pain. We will be trialing waveforms that are unique to Nuvectra's system. This is a small study that I hope will allow us to run additional larger studies. I think we can help a lot of people with back pain."

Dr. Amol Soin, founder and CEO of Soin Neuroscience, and pain management physician.

The study will be run in Dayton, OH. Patients who suffer from debilitating back may be considered good candidates for the study.

About Soin Neuroscience:

Soin Neuroscience (SNI) is a pharmaceutical startup company based in Dayton, OH that specializes in treating pain and other neurological conditions. Its lead compound, TV1001SR, is entering late stage trials to treat systemic sclerosis and diabetic peripheral neuropathy. SNI also has multiple other compounds in development including a way to restore functional motor and cognitive function after ischemic stroke, a method to treat intensive care unit myopathy, and is working on an option to treat Huntington's disease. The company was founded by Dr. Amol Soin who is also an inventor on most of the core technologies that are being developed. He can be reached at drsoin@soinneuroscience.com.

 (PRNewsfoto/Soin Neuroscience)

SOURCE Soin Neuroscience


These press releases may also interest you

at 04:00
SAN FRANCISCO, June 21, 2018 /PRNewswire-PRWeb/ -- San Francisco Dental Implant Center, one of the top-rated dental implant centers in San Francisco and the entire Bay Area, is proud to announce an update to its popular "All on Four" informational...

at 03:30
Malong Technologies today announced its selection to the World Economic Forum's 2018 class of Technology Pioneers. The World Economic Forum's Technology Pioneers community are early-stage companies from around the world that are involved in the...

at 03:30
Unilateral MRI-guided Focused Ultrasound Thalamotomy for Treatment-resistant Essential Tremor Recognised by National Institute for Health and Care Excellence  INSIGHTEC®, a global medical technology innovator of incisionless surgery, announced...

at 03:00
PHILADELPHIA, June 21, 2018 /PRNewswire-PRWeb/ -- Today, http://www.CPRTrainingFast.com announced that they will begin venturing into medical marijuana education and medical marijuana certifications for healthcare providers. They have launched...

at 03:00
El Naturalista, a company with more than 50 years of experience producing health and wellness supplements, offers an extended variety of natural products obtained through non-synthetic procedures ensuring a lower number of side effects. Muconatur, in...

at 02:33
Adverse patient safety events in the US and Western European healthcare systems impose an estimated cost burden of US$ 317.93 billion in 2016 and is estimated to increase at a CAGR of 3.2% reaching US$ 383.7 billion in 2022. The rising incidences of...




News published on 8 march 2018 at 18:18 and distributed by: